Quantcast
Tag archive for ‘Durata Therapeutics’
By Guest Author On Friday, January 5th, 2018
0 Comments

Different anxiety therapies and how they are carried out

Anxiety disorder is a very common problem these days. Incapacitating phobia, unrelenting worries, obsessive thoughts and panic attacks are some of the basic symptoms of anxiety problems in a person. But, when there More...

By The Dispatch On Friday, May 23rd, 2014
2 Comments

Dalvance receives FDA approval for the treatment of Staph and Strep skin infections

PRESS RELEASE The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections. MRSAImage/CDC Dalvance is intended to treat acute bacterial More...

By Robert On Monday, November 5th, 2012
0 Comments

Antibiotic candidate, dalbavancin, designated as a Qualified Infectious Disease Product by the FDA

The intravenous antibiotic product candidate, dalbavancin,  has been designated as a Qualified Infectious Disease Product (QIDP) by the Food and Drug Administration (FDA), making it eligible for fast-track status, More...


Recent Posts

Singapore Cryptocurrency License: A Major framework for Major players

October 26, 2021, Comments Off on Singapore Cryptocurrency License: A Major framework for Major players

DISPATCH BLOGS

Splash Page logo 300x146 Today in History